$2.50
+0.100 (+4.17%)
At Close: Jun 22, 2026
Head to Head Survey: Eli Lilly And Co (NYSE:LLY) versus Syros Pharmaceuticals (NYSE:SYRS)
06:28am, Saturday, 25'th Apr 2020
Eli Lilly And Co (NYSE:LLY) and Syros Pharmaceuticals (NASDAQ:SYRS) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their r
Lilly Reports Strong First-Quarter Financial Results, Adjusts EPS Guidance
10:25am, Thursday, 23'rd Apr 2020
Eli Lilly and Company (NYSE: LLY) today announced financial results for the first quarter of 2020.
Neurology at Forefront of FDA’s Complex Innovative Trial Design Pilot
01:57pm, Thursday, 16'th Apr 2020
The coronavirus pandemic has frozen many clinical trials and forced others to adapt in the face of overwhelmed healthcare systems around the world. When
Newsflash: AC Immune SA (NASDAQ:ACIU) Analysts Have Been Trimming Their Revenue Forecasts
12:04pm, Saturday, 04'th Apr 2020
The analysts covering AC Immune SA (NASDAQ:ACIU) delivered a dose of negativity to shareholders today, by making a...
AC Immune Presents the Latest Preclinical Data on Novel Drug Targets for Neurodegenerative Diseases
11:00am, Thursday, 02'nd Apr 2020
Seven presentations by AC Immune and its partners at AAT-AD/PD™ New data on early-stage TDP-43 and alpha-synuclein therapeutic and diagnostic candidates A lead.
Analysts Offer Insights on Healthcare Companies: ObsEva SA (OBSV), AC Immune SA (ACIU) and Co-Diagnostics (CODX)
11:15am, Wednesday, 01'st Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ObsEva SA (OBSV), AC Immune SA (ACIU) and Co-Diagnostics
Analysts Offer Insights on Healthcare Companies: ObsEva SA (NASDAQ: OBSV), AC Immune SA (NASDAQ: ACIU) and Co-Diagnostics (NASDAQ: CODX)
11:15am, Wednesday, 01'st Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ObsEva SA
AC Immune Reports Full-Year 2019 Financial Results and Provides 2020 R&D Outlook
11:00am, Monday, 30'th Mar 2020
Ongoing strong financial position with CHF 288.6 million in cash, ensuring the Company is fully financed through Q1 2024, excluding potential incoming milestonesReceived CHF 110.
Company News for Mar 24, 2020
01:54pm, Tuesday, 24'th Mar 2020
Companies in the news are: HAS, PCG, WTRH, ACIU
AC Immune Receives Second Milestone and New Milestone to Increase the Potential Deal Value of Lilly Morphomer™ Tau Partnership
11:00am, Monday, 23'rd Mar 2020
AC Immune SA (ACIU), a Swiss-based, clinical-stage biopharmaceutical company, today announced that it will receive a second milestone payment of CHF 10 million from Eli Lilly and Company on or before
Contrasting AC Immune (NASDAQ:ACIU) & Takeda Pharmaceutical (NASDAQ:TKPYY)
06:26am, Saturday, 21'st Mar 2020
AC Immune (NASDAQ:ACIU) and Takeda Pharmaceutical (OTCMKTS:TKPYY) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividend
Internationally Renowned Neurologist Dr. Juan Fortea Joins AC Immune’s Clinical Advisory Board
11:19am, Friday, 20'th Mar 2020
LAUSANNE, Switzerland, March 20, 2020 -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative.
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
11:37am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) * Biomerica, Inc. (NASDAQ: BMRA)( announced comm
The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
11:36am, Wednesday, 18'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 17) * BioNTech SE - ADR (NASDAQ: BNTX) * Regeneron P
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 16.) * BioNTech SE - ADR (NASDAQ: BNTX) (announced eff
Sign In
Buy ACIU